vs
Side-by-side financial comparison of C & F FINANCIAL CORP (CFFI) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $35.9M, roughly 1.6× C & F FINANCIAL CORP). C & F FINANCIAL CORP runs the higher net margin — 18.7% vs -83.0%, a 101.6% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 12.0%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 8.2%).
Sun Life Financial Inc. is a Canadian financial services company headquartered in Toronto, Ontario. Founded in 1865, it operates internationally in life insurance, wealth management, and asset management. As of 2024, the company manages over CAD$1.3 trillion in assets and serves clients in Canada, the United States, Asia, and other markets.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
CFFI vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.9M | $57.3M |
| Net Profit | $6.7M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | 22.6% | -82.2% |
| Net Margin | 18.7% | -83.0% |
| Revenue YoY | 12.0% | 36.9% |
| Net Profit YoY | 11.0% | -9.6% |
| EPS (diluted) | $2.08 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.9M | $57.3M | ||
| Q3 25 | $36.0M | $51.3M | ||
| Q2 25 | $36.4M | $48.5M | ||
| Q1 25 | $32.6M | $32.7M | ||
| Q4 24 | $32.0M | $41.8M | ||
| Q3 24 | $33.5M | $33.3M | ||
| Q2 24 | $31.2M | $29.1M | ||
| Q1 24 | $30.6M | $26.0M |
| Q4 25 | $6.7M | $-47.5M | ||
| Q3 25 | $7.1M | $-52.9M | ||
| Q2 25 | $7.7M | $-46.6M | ||
| Q1 25 | $5.4M | $-49.5M | ||
| Q4 24 | $6.0M | $-43.3M | ||
| Q3 24 | $5.4M | $-43.6M | ||
| Q2 24 | $5.0M | $-32.3M | ||
| Q1 24 | $3.4M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | 22.6% | -82.2% | ||
| Q3 25 | 24.5% | -102.6% | ||
| Q2 25 | 26.5% | -93.4% | ||
| Q1 25 | 20.0% | -143.7% | ||
| Q4 24 | 22.6% | -98.6% | ||
| Q3 24 | 19.9% | -132.0% | ||
| Q2 24 | 20.0% | -139.2% | ||
| Q1 24 | 13.1% | -538.7% |
| Q4 25 | 18.7% | -83.0% | ||
| Q3 25 | 19.6% | -103.1% | ||
| Q2 25 | 21.2% | -96.1% | ||
| Q1 25 | 16.5% | -151.4% | ||
| Q4 24 | 18.8% | -103.6% | ||
| Q3 24 | 16.1% | -131.2% | ||
| Q2 24 | 16.1% | -110.9% | ||
| Q1 24 | 11.1% | -544.4% |
| Q4 25 | $2.08 | $-0.73 | ||
| Q3 25 | $2.18 | $-0.82 | ||
| Q2 25 | $2.37 | $-0.75 | ||
| Q1 25 | $1.66 | $-0.81 | ||
| Q4 24 | $1.85 | $-0.71 | ||
| Q3 24 | $1.65 | $-0.73 | ||
| Q2 24 | $1.50 | $-0.55 | ||
| Q1 24 | $1.01 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $261.8M | $139.1M |
| Total Assets | $2.8B | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | — | $319.1M | ||
| Q1 24 | — | $201.2M |
| Q4 25 | $261.8M | $139.1M | ||
| Q3 25 | $253.3M | $148.8M | ||
| Q2 25 | $240.3M | $-11.9M | ||
| Q1 25 | $234.6M | $18.9M | ||
| Q4 24 | $226.4M | $21.7M | ||
| Q3 24 | $227.3M | $11.2M | ||
| Q2 24 | $218.5M | $39.3M | ||
| Q1 24 | $216.3M | $61.6M |
| Q4 25 | $2.8B | $480.2M | ||
| Q3 25 | $2.7B | $506.9M | ||
| Q2 25 | $2.7B | $372.7M | ||
| Q1 25 | $2.6B | $386.7M | ||
| Q4 24 | $2.6B | $392.3M | ||
| Q3 24 | $2.6B | $363.6M | ||
| Q2 24 | $2.5B | $381.8M | ||
| Q1 24 | $2.5B | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $24.5M | $-25.4M |
| Free Cash FlowOCF − Capex | $22.2M | — |
| FCF MarginFCF / Revenue | 61.8% | — |
| Capex IntensityCapex / Revenue | 6.5% | — |
| Cash ConversionOCF / Net Profit | 3.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | $42.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.5M | $-25.4M | ||
| Q3 25 | $23.4M | $-26.6M | ||
| Q2 25 | $-4.4M | $-23.3M | ||
| Q1 25 | $3.2M | $-40.4M | ||
| Q4 24 | $36.8M | $-18.8M | ||
| Q3 24 | $404.0K | $-25.2M | ||
| Q2 24 | $1.7M | $-29.1M | ||
| Q1 24 | $895.0K | $-40.7M |
| Q4 25 | $22.2M | — | ||
| Q3 25 | $22.7M | — | ||
| Q2 25 | $-5.0M | — | ||
| Q1 25 | $2.9M | — | ||
| Q4 24 | $33.3M | — | ||
| Q3 24 | $-1.6M | — | ||
| Q2 24 | $1.2M | — | ||
| Q1 24 | $410.0K | — |
| Q4 25 | 61.8% | — | ||
| Q3 25 | 63.0% | — | ||
| Q2 25 | -13.6% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 103.8% | — | ||
| Q3 24 | -4.9% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | 1.3% | — |
| Q4 25 | 6.5% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 10.9% | — | ||
| Q3 24 | 6.1% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | 3.65× | — | ||
| Q3 25 | 3.31× | — | ||
| Q2 25 | -0.57× | — | ||
| Q1 25 | 0.60× | — | ||
| Q4 24 | 6.09× | — | ||
| Q3 24 | 0.07× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.26× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CFFI
| Community Banking | $25.9M | 72% |
| Consumer Finance Segment | $7.0M | 19% |
| Mortgage Banking Segment | $1.9M | 5% |
| Other | $1.1M | 3% |
RYTM
Segment breakdown not available.
